Chronic urticaria and the pathogenic role of mast cells.

[1]  X. Solanich,et al.  Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial , 2023, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  M. Lebwohl,et al.  Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances , 2022, Allergy.

[3]  M. Maurer,et al.  Anti‐KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria , 2022, Allergy.

[4]  Yvonne Hui,et al.  Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist , 2022, Frontiers in Immunology.

[5]  K. Ozawa,et al.  Basophils activation of patients with chronic spontaneous urticaria in response to C5a despite failure to respond to IgE-mediated stimuli , 2022, Frontiers in Immunology.

[6]  M. Maurer,et al.  Urticaria , 2022, Nature Reviews Disease Primers.

[7]  Lea Kiefer,et al.  Evidence for histamine release in chronic inducible urticaria – A systematic review , 2022, Frontiers in Immunology.

[8]  W. Aberer,et al.  The Icatibant Outcome Survey: 10 years of experience with icatibant for patients with hereditary angioedema , 2022, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[9]  A. Zenclussen,et al.  Urticaria in Pregnancy and Lactation , 2022, Frontiers in Allergy.

[10]  M. Maurer,et al.  Autoimmune chronic spontaneous urticaria. , 2022, The Journal of allergy and clinical immunology.

[11]  Lei Zhu,et al.  The Role of Crosstalk of Immune Cells in Pathogenesis of Chronic Spontaneous Urticaria , 2022, Frontiers in Immunology.

[12]  T. Zuberbier,et al.  FcεRI‐ and MRGPRX2‐evoked acute degranulation responses are fully additive in human skin mast cells , 2022, Allergy.

[13]  S. Frischbutter,et al.  Mast cells, cortistatin, and its receptor, MRGPRX2, are linked to the pathogenesis of chronic prurigo. , 2022, The Journal of allergy and clinical immunology.

[14]  L. Vitale,et al.  Anti‐KIT monoclonal antibody CDX‐0159 induces profound and durable mast cell suppression in a healthy volunteer study , 2022, Allergy.

[15]  Katherine C. Chang,et al.  The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation , 2022, Frontiers in Immunology.

[16]  J. Bernstein,et al.  An Open-Label, Proof-of-Concept Study of Lirentelimab for Antihistamine-Resistant Chronic Spontaneous and Inducible Urticaria. , 2021, The Journal of allergy and clinical immunology.

[17]  M. Maurer,et al.  Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases , 2021, Nature Reviews Immunology.

[18]  T. Zuberbier,et al.  The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria , 2021, Allergy.

[19]  J. Marshall,et al.  Mast Cell Modulation of B Cell Responses: An Under-Appreciated Partnership in Host Defence , 2021, Frontiers in Immunology.

[20]  S. Valitutti,et al.  T helper cell-licensed mast cells promote inflammatory Th17 cells , 2021, bioRxiv.

[21]  E. Lion,et al.  Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones , 2021, Frontiers in Immunology.

[22]  K. Ozawa,et al.  The Role of Coagulation and Complement Factors for Mast Cell Activation in the Pathogenesis of Chronic Spontaneous Urticaria , 2021, Cells.

[23]  A. Knulst,et al.  Systemic and local evidence for complement involvement in chronic spontaneous urticaria , 2021, Clinical and translational allergy.

[24]  H. Ali,et al.  Substance P Serves as a Balanced Agonist for MRGPRX2 and a Single Tyrosine Residue Is Required for β-Arrestin Recruitment and Receptor Internalization , 2021, International journal of molecular sciences.

[25]  A. Kaplan,et al.  The Pathogenesis of Chronic Spontaneous Urticaria: The Role of Infiltrating Cells. , 2021, The journal of allergy and clinical immunology. In practice.

[26]  M. Maurer,et al.  Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review , 2021, Allergy.

[27]  R. Cardona,et al.  Presence of IgE Autoantibodies Against Eosinophil Peroxidase and Eosinophil Cationic Protein in Severe Chronic Spontaneous Urticaria and Atopic Dermatitis , 2021, Allergy, asthma & immunology research.

[28]  Sabag D. Adi,et al.  The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A , 2021, Biomolecules.

[29]  A. Kaplan,et al.  Biologics for the Use in Chronic Spontaneous Urticaria: When and Which. , 2021, The journal of allergy and clinical immunology. In practice.

[30]  G. Pejler,et al.  Novel Strategies to Target Mast Cells in Disease , 2021, Journal of Innate Immunity.

[31]  L. Aira,et al.  Skin-homing regulatory B cells required for suppression of cutaneous inflammation. , 2021, The Journal of investigative dermatology.

[32]  M. Babina,et al.  Mas-related G protein-coupled receptor X2 and its activators in dermatologic allergies. , 2020, The Journal of allergy and clinical immunology.

[33]  E. Toraih,et al.  Interleukin 17 receptor A haplotype analysis in chronic spontaneous urticaria: A preliminary study , 2020, Journal of cosmetic dermatology.

[34]  Y. Matsuo,et al.  Coagulation factors induce human skin mast cell- and basophil-degranulation via activation of complement 5 and the C5a receptor. , 2020, The Journal of allergy and clinical immunology.

[35]  Xinzhong Dong,et al.  MRGPRX2 Activation Causes Increased Skin Reactivity in Chronic Spontaneous Urticaria Patients. , 2020, The Journal of investigative dermatology.

[36]  S. Meri,et al.  Mast cells and complement system: Ancient interactions between components of innate immunity , 2020, Allergy.

[37]  M. Maurer,et al.  Interleukin‐17 is a potential player and treatment target in severe chronic spontaneous urticaria , 2020, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[38]  M. Tsai,et al.  Mast Cells in Inflammation and Disease: Recent Progress and Ongoing Concerns. , 2020, Annual review of immunology.

[39]  F. Wang,et al.  The Return of the Mast Cell: New Roles in Neuroimmune Itch Biology. , 2020, The Journal of investigative dermatology.

[40]  S. Frischbutter,et al.  The role of eosinophils in chronic spontaneous urticaria. , 2020, The Journal of allergy and clinical immunology.

[41]  M. Christian,et al.  Crosstalk Between Mast Cells and Adipocytes in Physiologic and Pathologic Conditions , 2020, Clinical Reviews in Allergy & Immunology.

[42]  S. Ferrucci,et al.  Co‐occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria , 2020, Clinical and experimental immunology.

[43]  I. Adcock,et al.  The Role of Mast Cells in IgE-Independent Lung Diseases , 2020, Clinical Reviews in Allergy & Immunology.

[44]  L. Bielory,et al.  Mast Cell Biology at Molecular Level: a Comprehensive Review , 2019, Clinical Reviews in Allergy & Immunology.

[45]  A. Nakao,et al.  Resveratrol inhibits IL-33–mediated mast cell activation by targeting the MK2/3–PI3K/Akt axis , 2019, Scientific Reports.

[46]  C. Bebbington,et al.  Siglec-8 antibody reduces eosinophil and mast cell infiltration in a transgenic mouse model of eosinophilic gastroenteritis. , 2019, JCI insight.

[47]  C. Grattan,et al.  Is chronic urticaria more than skin deep? , 2019, Clinical and Translational Allergy.

[48]  D. Ribatti,et al.  Mast cell-mediated mechanistic pathways in organ transplantation. , 2019, European journal of pharmacology.

[49]  D. Greiner,et al.  AK002, a Humanized Sialic Acid-Binding Immunoglobulin-Like Lectin-8 Antibody that Induces Antibody-Dependent Cell-Mediated Cytotoxicity against Human Eosinophils and Inhibits Mast Cell-Mediated Anaphylaxis in Mice , 2019, International Archives of Allergy and Immunology.

[50]  T. Kupper,et al.  T cells and the skin: from protective immunity to inflammatory skin disorders , 2019, Nature Reviews Immunology.

[51]  F. Redegeld,et al.  Role of Mast Cells in Shaping the Tumor Microenvironment , 2019, Clinical Reviews in Allergy & Immunology.

[52]  P. Skov,et al.  GSK2646264, a spleen tyrosine kinase inhibitor, attenuates the release of histamine in ex vivo human skin , 2019, British journal of pharmacology.

[53]  A. Kasperska‐Zając,et al.  Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria , 2019, Allergy, Asthma & Clinical Immunology.

[54]  P. S. Santa Maria,et al.  A Review of the Contribution of Mast Cells in Wound Healing: Involved Molecular and Cellular Mechanisms , 2019, Clinical Reviews in Allergy & Immunology.

[55]  Michael T. Beste,et al.  Omalizumab normalizes the gene expression signature of lesional skin in patients with chronic spontaneous urticaria: A randomized, double‐blind, placebo‐controlled study , 2018, Allergy.

[56]  Joaquín Sánchez,et al.  Causal Relationship Between Anti-TPO IgE and Chronic Urticaria by In Vitro and In Vivo Tests , 2018, Allergy, asthma & immunology research.

[57]  S. Frischbutter,et al.  Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity and poor response to treatment. , 2019, The journal of allergy and clinical immunology. In practice.

[58]  L. Bjermer,et al.  Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights , 2018, Clinical Reviews in Allergy & Immunology.

[59]  G. Vena,et al.  Focus on the role of substance P in chronic urticaria , 2018, Clinical and Molecular Allergy.

[60]  M. Tsai,et al.  Mast cells as sources of cytokines, chemokines, and growth factors , 2018, Immunological reviews.

[61]  L. Bielory,et al.  Clinical implications of mast cell involvement in allergic conjunctivitis , 2018, Allergy.

[62]  D. Terhorst,et al.  In chronic spontaneous urticaria, high numbers of dermal endothelial cells, but not mast cells, are linked to recurrent angio‐oedema , 2018, Clinical and experimental dermatology.

[63]  M. Maurer,et al.  The role and relevance of mast cells in urticaria , 2018, Immunological reviews.

[64]  O. Schmetzer,et al.  IL‐24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria , 2017, The Journal of allergy and clinical immunology.

[65]  F. Redegeld,et al.  Mast Cells as Drivers of Disease and Therapeutic Targets. , 2017, Trends in immunology.

[66]  Jie Zheng,et al.  Pivotal Role of Lesional and Perilesional T/B Lymphocytes in Pemphigus Pathogenesis. , 2017, The Journal of investigative dermatology.

[67]  L. Schwartz,et al.  Chronic Idiopathic Urticaria: Systemic Complaints and Their Relationship with Disease and Immune Measures. , 2017, The journal of allergy and clinical immunology. In practice.

[68]  F. Levi-Schaffer,et al.  Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer , 2017, Front. Med..

[69]  S. Wöhrl,et al.  Mastocytosis: from a Molecular Point of View , 2017, Clinical Reviews in Allergy & Immunology.

[70]  O. Schmetzer,et al.  Autoimmune chronic spontaneous urticaria: What we know and what we do not know , 2017, The Journal of allergy and clinical immunology.

[71]  J. Yélamos,et al.  Transcriptome analysis of severely active chronic spontaneous urticaria shows an overall immunological skin involvement , 2017, Allergy.

[72]  R. Hillenbrand,et al.  Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin , 2017, Theranostics.

[73]  M. Tiemann,et al.  Characterization of mast cell populations using different methods for their identification , 2017, Histochemistry and Cell Biology.

[74]  A. Knulst,et al.  Effectiveness and safety of antihistamines up to fourfold or higher in treatment of chronic spontaneous urticaria , 2017, Clinical and Translational Allergy.

[75]  R. Sackstein,et al.  T-Lymphocyte Homing: An Underappreciated yet Critical Hurdle for Successful Cancer Immunotherapy , 2017, Laboratory investigation; a journal of technical methods and pathology.

[76]  Y. Choi,et al.  Association of TG2 from mast cells and chronic spontaneous urticaria pathogenesis. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[77]  H. Stark,et al.  Human basophil chemotaxis and activation are regulated via the histamine H4 receptor , 2016, Allergy.

[78]  Kristina M. Ilieva,et al.  IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin , 2016, Scientific Reports.

[79]  G. Nilsson,et al.  Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases , 2016, The World Allergy Organization journal.

[80]  G. Ruthel,et al.  IL-10+ Innate-like B Cells Are Part of the Skin Immune System and Require α4β1 Integrin To Migrate between the Peritoneum and Inflamed Skin , 2016, The Journal of Immunology.

[81]  J. Krueger,et al.  Diverse activation and differentiation of multiple B-cell subsets in patients with atopic dermatitis but not in patients with psoriasis. , 2016, The Journal of allergy and clinical immunology.

[82]  A. B. Kay,et al.  Elevations in T‐helper‐2‐initiating cytokines (interleukin‐33, interleukin‐25 and thymic stromal lymphopoietin) in lesional skin from chronic spontaneous (‘idiopathic’) urticaria , 2015, The British journal of dermatology.

[83]  S. Dreskin,et al.  Gene expression profiles in chronic idiopathic (spontaneous) urticaria , 2015, Allergy & rhinology.

[84]  M. Shima,et al.  Increased thrombin generation potential in patients with chronic spontaneous urticaria. , 2015, Allergology international : official journal of the Japanese Society of Allergology.

[85]  M. Maurer,et al.  Substance P is upregulated in the serum of patients with chronic spontaneous urticaria. , 2014, The Journal of investigative dermatology.

[86]  H. Kita,et al.  Expression of Mas-related gene X2 on mast cells is upregulated in the skin of patients with severe chronic urticaria. , 2014, The Journal of allergy and clinical immunology.

[87]  H. Kita,et al.  Elevations in vascular markers and eosinophils in chronic spontaneous urticarial weals with low-level persistence in uninvolved skin , 2014, The British journal of dermatology.

[88]  C. Rodrigo,et al.  Leukotriene receptor antagonists for chronic urticaria: a systematic review , 2014, Allergy, Asthma & Clinical Immunology.

[89]  Hae‐Sim Park,et al.  Molecular Genetic Mechanisms of Chronic Urticaria , 2013, Allergy, asthma & immunology research.

[90]  P. Migliorini,et al.  CCL5/RANTES, sVCAM-1, and sICAM-1 in Chronic Spontaneous Urticaria , 2013, International Archives of Allergy and Immunology.

[91]  Y. Okayama,et al.  Significantly High Levels of Anti-dsDNA Immunoglobulin E in Sera and the Ability of dsDNA to Induce the Degranulation of Basophils from Chronic Urticaria Patients , 2013, International Archives of Allergy and Immunology.

[92]  E. Conway,et al.  Thrombin generates previously unidentified C5 products that support the terminal complement activation pathway. , 2012, Blood.

[93]  T. Satoh,et al.  Basophil recruitment and activation in inflammatory skin diseases , 2011, Allergy.

[94]  K. Schäkel,et al.  Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase. , 2011, The Journal of allergy and clinical immunology.

[95]  P. Martus,et al.  IgE Mediated Autoallergy against Thyroid Peroxidase – A Novel Pathomechanism of Chronic Spontaneous Urticaria? , 2011, PloS one.

[96]  F. Levi-Schaffer,et al.  Physical interactions between mast cells and eosinophils: a novel mechanism enhancing eosinophil survival in vitro , 2011, Allergy.

[97]  L. Schwartz,et al.  Serum total tryptase levels are increased in patients with active chronic urticaria , 2010, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[98]  R. Noelle,et al.  Cellular sources and immune functions of interleukin-9 , 2010, Nature Reviews Immunology.

[99]  F. Levi-Schaffer,et al.  Mast cells and eosinophils: the two key effector cells in allergic inflammation , 2009, Inflammation Research.

[100]  D. Grigoryev,et al.  Gene Expression Profiling of Nonlesional Skin from Chronic Idiopathic Urticaria Subjects is Distinct from Normal Nonatopic Skin , 2009 .

[101]  A. J. da Silva Duarte,et al.  Increased circulating pro-inflammatory cytokines and imbalanced regulatory T-cell cytokines production in chronic idiopathic urticaria. , 2008, International immunopharmacology.

[102]  L. Schwartz,et al.  Generation of Anaphylatoxins by Human β-Tryptase from C3, C4, and C51 , 2008, The Journal of Immunology.

[103]  B. Engelmann,et al.  bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only. , 2006 .

[104]  G. Faa,et al.  Chronic urticaria is associated with mast cell infiltration in the gastroduodenal mucosa , 2006, Virchows Archiv.

[105]  M. Manfredi,et al.  Chronic idiopathic urticaria: infiltrating cells and related cytokines in autologous serum-induced wheals. , 2005, Clinical immunology.

[106]  O. Mandelboim,et al.  2B4 (CD244) Is Expressed and Functional on Human Eosinophils1 , 2005, The Journal of Immunology.

[107]  M. Sanak,et al.  Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma. , 2004, The Journal of allergy and clinical immunology.

[108]  M. Manfredi,et al.  Infiltrating cells and related cytokines in lesional skin of patients with chronic idiopathic urticaria and positive autologous serum skin test , 2003, Experimental dermatology.

[109]  C. Grattan,et al.  Blood basophil numbers in chronic ordinary urticaria and healthy controls: diurnal variation, influence of loratadine and prednisolone and relationship to disease activity , 2003, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[110]  K. Ohta,et al.  Concerted expression of eotaxin-1, eotaxin-2, and eotaxin-3 in human bronchial epithelial cells. , 2003, Cellular immunology.

[111]  A. Kaplan,et al.  Secretion of Cytokines, Histamine and Leukotrienes in Chronic Urticaria , 2002, International Archives of Allergy and Immunology.

[112]  A. Kay,et al.  TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. , 2002, The Journal of allergy and clinical immunology.

[113]  A. Kaplan,et al.  A role for C5a in augmenting IgG-dependent histamine release from basophils in chronic urticaria. , 2002, The Journal of allergy and clinical immunology.

[114]  G. Vena,et al.  Mast‐cell phenotype in urticaria , 2001, Allergy.

[115]  K. Sugamura,et al.  CRTH2, an orphan receptor of T‐helper‐2‐cells, is expressed on basophils and eosinophils and responds to mast cell‐derived factor(s) , 1999, FEBS letters.

[116]  A. Kaplan,et al.  Complement dependence of histamine release in chronic urticaria. , 1999, The Journal of allergy and clinical immunology.

[117]  F. Mahmoud,et al.  Elevated B‐Lymphocyte Levels in Lesional Tissue of Non‐Arthritic Psoriasis , 1999, The Journal of dermatology.

[118]  M. Sticherling,et al.  Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. , 1999, The Journal of allergy and clinical immunology.

[119]  K. Kontou-Fili,et al.  Cutaneous responses to substance P and calcitonin gene‐related peptide in chronic urticaria: the effect of cetirizine and dimethindene , 1999, Allergy.

[120]  B. Henz,et al.  Microscopic morphology of different types of urticaria. , 1998, Archives of dermatology.

[121]  D. Schadendorf,et al.  Enhanced P-selectin expression in chronic and dermographic urticaria. , 1997, International archives of allergy and immunology.

[122]  T. Kasahara,et al.  Eotaxin is a potent chemotaxin for human basophils. , 1997, Biochemical and biophysical research communications.

[123]  T. Zuberbier,et al.  Histamine releasability of basophils and skin mast cells in chronic urticaria , 1996, Allergy.

[124]  J. Kinet,et al.  Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients? , 1995, The Journal of clinical investigation.

[125]  C. Kepley,et al.  Mast cell number and phenotype in chronic idiopathic urticaria. , 1995, The Journal of allergy and clinical immunology.

[126]  D. Macdonald,et al.  Mast cells and T lymphocytes in chronic urticaria , 1995, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[127]  M. Joseph,et al.  Tumor necrosis factor-α release during systemic reaction in cold urticaria , 1994 .

[128]  K. Kishi,et al.  Induction of human IgE synthesis in B cells by mast cells and basophils , 1993, Nature.

[129]  J. Hébert,et al.  Chronic idiopathic urticaria: possible contribution of histamine-releasing factor to pathogenesis. , 1993, The Journal of allergy and clinical immunology.

[130]  J. Kochan,et al.  Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. , 1993, The New England journal of medicine.

[131]  J. Hébert,et al.  Chronic idiopathic urticaria: profiles of skin mast cell histamine release during active disease and remission. , 1992, The Journal of allergy and clinical immunology.

[132]  P. Kuna,et al.  Monocyte chemotactic and activating factor is a potent histamine- releasing factor for human basophils , 1992, The Journal of experimental medicine.

[133]  M. Greaves,et al.  Detection of circulating histamine releasing autoantibodies with functional properties of anti‐IgE in chronic urticaria , 1991, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[134]  B. Deleuran,et al.  Increased tryptase levels in suction‐blister fluid from patients with urticaria , 1991, The British journal of dermatology.

[135]  P. Ind,et al.  Leukotriene E4 release in cold urticaria , 1989, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[136]  A. Ormerod,et al.  Prostaglandin D2 and histamine release in cold urticaria unaccompanied by evidence of platelet activation. , 1988, The Journal of allergy and clinical immunology.

[137]  J. Hébert,et al.  Analysis of compound 48/80-induced skin histamine release and leukotriene production in chronic urticaria. , 1988, The Journal of allergy and clinical immunology.

[138]  J. Hébert,et al.  Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticaria. , 1986, The Journal of allergy and clinical immunology.

[139]  J. Elias,et al.  Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. , 1986, The Journal of allergy and clinical immunology.

[140]  R. Farr,et al.  Association of platelet-activating factor with primary acquired cold urticaria. , 1985, The New England journal of medicine.

[141]  E. Razin,et al.  Thrombin-induced degranulation of cultured bone marrow-derived mast cells. , 1984, Journal of immunology.

[142]  P. Anderson,et al.  Lymphocyte subpopulations in the skin of patients with chronic urticaria. , 1983, The Journal of allergy and clinical immunology.

[143]  ATRACURIUM , 1983, The Lancet.

[144]  J. Elias,et al.  Histologic studies of chronic idiopathic urticaria. , 1983, The Journal of allergy and clinical immunology.

[145]  P. Phanuphak,et al.  Skin histamine in chronic urticaria. , 1980, The Journal of allergy and clinical immunology.

[146]  A. Kaplan,et al.  Assessment of tissue fluid histamine levels in patients with urticaria. , 1978, The Journal of allergy and clinical immunology.

[147]  M. I. Levine.  Chronic urticaria. , 1975, The Journal of allergy and clinical immunology.

[148]  H. Rorsman,et al.  BASOPENIA IN URTICARIA , 1961, Acta allergologica.